BACKGROUND: Early detection of atrial fibrillation (AF) is essential for preventing ischemic stroke and other cardiovascular complications. However, the incidence and prognosis of AF in the general ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, evaluating 12-month kidney function ...
Objective To (1) describe the incidence and characteristics of injuries and illnesses reported by Team USA athletes competing ...
Objectives Bisphenol A (BPA), a xenoestrogen that can alter DNA methylation status, has been implicated in the pathogenesis ...
Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback